Measurement of Stress During Anesthesia With "Pain Detector" on Patients Receiving Atropine

NCT ID: NCT00328900

Last Updated: 2012-06-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

24 patients randomly divided into two groups, one of the groups receiving atropine in addition to the planned anaesthesia. Skin conductance parameters to be compared between the two groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Skin conductance (SC), in terms of numbers of skin conduction fluctuations (NSCF), amplitude and mean skin conductance level, reflect the activity in the sympathetic postganglionic cholinergic fibers which innervate the palmar and plantar sweat glands. Skin conductance, especially numbers of skin conductance fluctuations, may be a promising tool to monitor anesthesia. Atropine, an anticholinergic agent, acts as an antagonist on the muscarinic receptors of the sweat glands and inhibits their secretion in a dose-dependent way. The aim of this study was to find out to what degree SC is influenced by i.v. administration of atropine.

Study hypothesis: SC is not influenced by i.v. administration of atropine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemorrhoids Fissure in Ano

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Administration of 0,7 mg of atropine

Intervention Type DRUG

Measurement of skin conductance with Pain detector

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients in ASA-group 1-2
* Operations (anal fissures, anal fistulas and haemorrhoids) lasting for less than one hour
* informed consent
* BMI \<30

Exclusion Criteria

* Patients using any medication known to influence the autonomous nervous system
* Patients with contraindications to atropine (e.i. fibrillation, glaucoma ect)
* BMI \>30
* Pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rikshospitalet University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rikshospitalet, UIO

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hanne Storm, PhD

Role: STUDY_DIRECTOR

Rikshospitalet University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ulleval University Hospital

Oslo, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hanne Storm, PhD

Role: CONTACT

+47 23074398

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hanne Storm, PhD

Role: primary

+47 23074398

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S-03113

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.